WAYNE ROCKHILL: Open Payments
NPI 1497188163 · WATERBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 26 payments from 12 companies in 2025. Trend: 2023 $193 · 2024 $1,108 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 5 | $311 |
| Alnylam Pharmaceuticals Inc. | 4 | $118 |
| Edwards Lifesciences Corporation | 2 | $82 |
| Bracco Diagnostics Inc. | 2 | $66 |
| Novartis Pharmaceuticals Corporation | 2 | $63 |
| Boston Scientific Corporation | 1 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Abbott Laboratories | 2 | $35 |
Products named: COREVALVE EVOLUT R, Lumason, AMVUTTRA, LEQVIO, FARAPULSE, ONPATTRO, WAINUA, Kerendia.
Industry payments across CT — which companies pay providers there.
